Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2011
06/14/2011US7962289 System, method, and computer product for exon array analysis
06/14/2011US7960627 Plants and seeds of hybrid corn variety CH986372
06/14/2011US7960626 Plants and seeds of hybrid corn variety CH621142
06/14/2011US7960625 Plants and seeds of hybrid corn variety CH938558
06/14/2011US7960624 Plants and seeds of hybrid corn variety CH794019
06/14/2011US7960620 Cotton variety 07W903DF
06/14/2011US7960619 Soybean variety RJS42001
06/14/2011US7960618 Soybean variety RJS47002
06/14/2011US7960617 Lettuce cultivar 50-0501050-B
06/14/2011US7960616 Directed evolution of GRG31 EPSP synthase enzyme
06/14/2011US7960615 GRG36: novel EPSP synthase gene conferring herbicide resistance
06/14/2011US7960614 Plant transformation and selection
06/14/2011US7960613 Plants with altered root architecture, involving the rum1 gene, related constructs and methods
06/14/2011US7960611 Method for promoting efficiency of gene introduction into plant cells
06/14/2011US7960610 Using vector transformation to generate disease, insect and herbicide resistant plants
06/14/2011US7960609 Plant vector pBSNB-TEV, vectors derived therefrom, and methods of use
06/14/2011US7960608 Modification of flavonoid biosynthesis in plants
06/14/2011US7960607 Plants having modified growth characteristics and a method for making the same
06/14/2011US7960606 Mouse model of chronic heart failure and coronary atherosclerosis regression
06/14/2011US7960541 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
06/14/2011US7960537 Polynucleotides for use as tags and tag complements, manufacture and use thereof
06/14/2011US7960536 Artificially generated promoter sequences for use in monitoring transcription factor binding; gene expression regulation
06/14/2011US7960535 Recombinant lipidated PsaA protein, methods of preparation and use
06/14/2011US7960534 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
06/14/2011US7960533 Nucleic acids coding for adhesion factor of group B Streptococcus, adhesion factors of group B Streptococcus and further uses thereof
06/14/2011US7960531 EG-VEGF nucleic acids and polypeptides and methods of use
06/14/2011US7960529 Bone delivery conjugates and method of using same to target proteins to bone
06/14/2011US7960528 Perhydrolase providing improved peracid stability
06/14/2011US7960527 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer
06/14/2011US7960525 Gene repair involving in vivo excision of targeting DNA
06/14/2011US7960524 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest
06/14/2011US7960514 IL-7 fusion proteins
06/14/2011US7960507 Tumor associated antigen peptides and use of same as anti-tumor vaccines
06/14/2011US7960364 Methods for modulating the efficacy of nucleic acid based therapies
06/14/2011US7960361 Formulating an anti-cancer vaccine comprising an agent that can stimulate an immune response against IL-13R alpha 2 outside of the subject, and administering the vaccine to the subject
06/14/2011US7960359 Methods and compositions involving miRNA and miRNA inhibitor molecules
06/14/2011US7960358 Antisense modulation of stearoyl-CoA desaturase expression
06/14/2011US7960355 Compositions and methods for the modulation of the expression of B7 protein
06/14/2011US7960173 Cardiac conduction system cells and uses thereof
06/14/2011US7960163 Matriptase, a serine protease and its applications
06/14/2011US7960161 Alpha-amylase mutants
06/14/2011US7960160 Hydrolase expressed in transgenic plants for improving feed digestibility in baking and brewing
06/14/2011US7960159 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions
06/14/2011US7960156 Glucose dehydrogenase and method for producing the dehydrogenase
06/14/2011US7960155 Cytochrome p450 monooxygenases and their use for oxidizing organic compounds
06/14/2011US7960154 Polyester-based-plastic-degrading bacteria, polyester-based-plastic-degrading enzymes and polynucleotides encoding the enzymes
06/14/2011US7960152 Methods for production of xylitol in microorganisms
06/14/2011US7960150 Production of a lipid acyltransferase from transformed Bacillus licheniformis cells
06/14/2011US7960149 Polypeptides having beta-glucosidase activity and polynucleotides encoding same
06/14/2011US7960147 Purification of Dna, Rna; hydration, mixing with chaotropic agent and reducing agents; heating controlling temperature; polymerase chain reaction, amplification
06/14/2011US7960146 Nucleotide sequences coding enzymatic polypeptide for use in the preparation of bread doughs
06/14/2011US7960143 Method for simultaneous production of multiple proteins; vectors and cells for use therein
06/14/2011US7960142 Stabilized polypeptide compositions
06/14/2011US7960141 Systems for the expression of orthogonal translation components in eubacterial host cells
06/14/2011US7960140 Avidin mutants
06/14/2011US7960128 TRP8, a transient receptor potential channel expressed in taste receptor cells
06/14/2011US7960127 Using channel protein to identify inhibitors of bitter and/or sweet taste preception
06/14/2011US7960103 Method for obtaining new life forms
06/14/2011US7960102 Regulated aptamer therapeutics
06/14/2011US7959933 Activatable recombinant neurotoxins
06/14/2011US7959930 Rescue of influenza virus
06/14/2011US7959923 Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA
06/14/2011US7959918 Methods for treating vascular disease
06/14/2011US7959916 Negative immunomodulation of immune responses by ERp5
06/14/2011US7959910 C-terminally truncated interferon alpha variants
06/14/2011US7959909 Cysteine variants of interferon gamma
06/14/2011CA2600177C Human skin equivalents expressing exogenous polypeptides
06/14/2011CA2581226C Thermostable mutants of pyrroloquinoline quinone dependent glucose dehydrogenase
06/14/2011CA2481844C System for tracing animal products
06/14/2011CA2459354C Amplification and detection reagents for hiv-1
06/14/2011CA2446260C Novel expression vectors and uses thereof
06/14/2011CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression
06/14/2011CA2413546C Modification of hepatitis b core antigen
06/14/2011CA2405084C Neutralizing immunogenic hev polypeptides
06/14/2011CA2399846C Gm-negative ehv-mutants
06/14/2011CA2369622C Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment
06/14/2011CA2359705C Chromatographic process for purification of albumin
06/14/2011CA2324853C Monoclonal and chimeric antibodies specific for human tumor necrosis factor
06/14/2011CA2322700C Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to binds to preselected sites
06/14/2011CA2311646C Tsa305 gene
06/14/2011CA2309315C Adenovirus vectors and method for reducing homologous recombination phenomena
06/14/2011CA2301327C Use of herpes vectors for tumor therapy
06/14/2011CA2297786C New immunoprotective influenza antigen and its use in vaccination
06/14/2011CA2293829C Methods and compositions for galactosylated glycoproteins
06/14/2011CA2210732C Recombinant swinepox virus
06/14/2011CA2182621C Galanin receptor, nucleic acids, transformed cells and uses thereof
06/14/2011CA2178212C Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications
06/10/2011CA2724132A1 Amplification system with spatial separation
06/10/2011CA2724106A1 Multiwell plate and lid
06/09/2011WO2011069155A1 Compositions and methods for inhibition of vegf
06/09/2011WO2011069033A1 Recombinant bacteria for producing glycerol and glycerol-derived products from sucrose
06/09/2011WO2011068993A1 Compositions and methods for increasing serum half-life of fc fusion proteins.
06/09/2011WO2011068918A1 Compositions and methods for treatment of cancer using tissue-specific oncolytic adenoviruses
06/09/2011WO2011068909A2 Aptamer cell compositions
06/09/2011WO2011068869A1 17-AAG POTENTIATING MicroRNAs
06/09/2011WO2011068865A1 Micro-rna-101 promotes estrogen-independent growth and confers tamoxifen resistance in er-positive cancer cells
06/09/2011WO2011068567A1 Novel hydroxyphenylpyruvate dioxygenase polypeptides and methods of use
06/09/2011WO2011068546A2 Prognosis, diagnosis and identification of multiple myeloma based on global gene expression profiling
06/09/2011WO2011068468A1 Improved media compositions, selection methods and agrobacterium strains for transformation of plants
06/09/2011WO2011068341A2 Gene and protein for biosynthesis of tricyclocompounds